Table 2

The effects of inhibitors on AII eEPSC amplitude and mEPSC frequency

	Data	Data structure	Type of test	Power	Mean ± SEM	Number of cells
	Effect on AII eEPSC amplitude
	Control	Non-normal distribution			1.00 ± 0.00
	50 μm W-7	Normal distribution			0.28 ± 0.05	9
	100 μm ML-9	Non-normal distribution			0.12 ± 0.04	10
	4 μm KN-62	Normal distribution			0.85 ± 0.07	10
	40 μm MMPX	Non-normal distribution			0.82 ± 0.16	8
	1 μm ascomycin	Normal distribution			0.73 ± 0.07	8
a	Control vs W-7		Wilcoxon signed-rank test	p = 0.0039		9
b	Control vs ML-9		Wilcoxon signed-rank test	p = 0.0020		10
c	Control vs KN-62		Wilcoxon signed-rank test	p = 0.0586		10
d	Control vs MMPX		Wilcoxon signed-rank test	p = 0.4609		8
e	Control vs ascomycin		Wilcoxon signed-rank test	p = 0.0078		8
	Effect on AII mEPSC frequency
	Control	Non-normal distribution			1.00 ± 0.00
	50 μm W-7	Non-normal distribution			5.95 ± 0.86	15
	100 μm ML-9	Normal distribution			7.19 ± 1.32	10
	4 μm KN-62	Normal distribution			0.88 ± 0.07	11
	40 μm MMPX	Normal distribution			1.35 ± 0.23	8
	1 μm ascomycin	Normal distribution			0.94 ± 0.10	15
f	Control vs W-7		Wilcoxon signed-rank test	p < 0.0001		15
g	Control vs ML-9		Wilcoxon signed-rank test	p = 0.0020		10
h	Control vs KN-62		Wilcoxon signed-rank test	p = 0.2139		11
i	Control vs MMPX		Wilcoxon signed-rank test	p = 0.3828		8
j	Control vs ascomycin		Wilcoxon signed-rank test	p = 0.3591		15